Science Explorer Back to mapMap

Most cited papers from Instituto Médico DAMIC

What are the most cited papers from Instituto Médico DAMIC?

The most cited paper from Instituto Médico DAMIC is "Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction" (Bertram Pitt, Willem J. Remme, Faiez M. Zannad et al., 2003), with 4,965 citations. Next come "Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II" (1,964) and "Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk" (745).

Showing 50 of 63 papers. Every paper with more than 4 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction Bertram Pitt, Willem J. Remme, Faiez M. Zannad et al. · New England Journal of Medicine Open access 2 Apr 2003 4,965
2 Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II Bertram Pitt, Philip Alexander Poole-Wilson, Robert Segal et al. · The Lancet May 2000 1,964
3 Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk Aruna D. Pradhan et al. · New England Journal of Medicine Open access 5 Nov 2022 745
4 Eplerenone Reduces Mortality 30 Days After Randomization Following Acute Myocardial Infarction in Patients With Left Ventricular Systolic Dysfunction and Heart Failure Bertram Pitt, Harvey Douglas White, José Carlos Nicolau et al. · Journal of the American College of Cardiology Open access 30 Jun 2005 387
5 A Polypill Strategy to Improve Adherence Jose Maria Castellano et al. · Journal of the American College of Cardiology Open access Sep 2014 352
6 The Concepts of the Ventral Striatopallidal System and Extended Amygdala José S. de Olmos, Lennart Heimer · Annals of the New York Academy of Sciences Jun 1999 347
7 Substantia innominata: a notion which impedes clinical–anatomical correlations in neuropsychiatric disorders Lennart Heimer, Richard E. Harlan, George F. Alheid et al. · Neuroscience 1997 294
8 WHF IASC Roadmap on Chagas Disease Luis Eduardo Echeverría, Rachel R. Marcus, Gabriel Novick et al. · Global Heart Open access 30 Mar 2020 155
9 The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential Jean‐Charles Fruchart et al. · Cardiovascular Diabetology Open access 4 Jun 2019 145
10 Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction Renato D. Lópes et al. · Circulation Open access 29 Aug 2020 124
11 Antiproteinuric efficacy of eplerenone, enalapril, and eplerenone/enalapril combination therapy in diabetic hypertensives with microalbuminuria Murray Epstein · American Journal of Hypertension Apr 2002 116
12 Evolocumab in Patients without a Previous Myocardial Infarction or Stroke Erin Ann Bohula et al. · New England Journal of Medicine 8 Nov 2025 104
13 A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure John J.V. McMurray et al. · European Heart Journal Open access 21 Nov 2014 96
14 Patients with chronic prostatitis/chronic pelvic pain syndrome show T helper type 1 (Th1) and Th17 self‐reactive immune responses specific to prostate and seminal antigens and diminished semen quality Ruben Dario Motrich, María Laura Breser, Rosa Isabel Molina et al. · British Journal of Urology Open access 21 May 2020 91
15 Presence of INFγ-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients Ruben Dario Motrich, Mariana Maccioni, Rosa Isabel Molina et al. · Clinical Immunology 26 Apr 2005 86
16 New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease Alberto J. Lorenzatti, Peter Paul Toth · European Cardiology Review Open access 26 Feb 2020 67
17 Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER Xiaowen Wang et al. · Circulation Open access 7 Nov 2022 60
18 Valsartan/Hydrochlorothiazide is Effective in Hypertensive Patients Inadequately Controlled by Valsartan Monotherapy Jean-Michel Mallion, Renzo Carretta, Peter Trenkwalder et al. · Blood Pressure Open access 2003 59
19 Chagas Disease and Heart Failure: An Expanding Issue Worldwide Felipe A. Martínez, Eduardo Roque Perna, Sergio V. Perrone et al. · European Cardiology Review Open access 22 May 2019 54
20 Prevalence and Impact of Treatment-Resistant Depression in Latin America: a Prospective, Observational Study Bernardo Soares, Gabriela Kanevsky, Chei Tung Teng et al. · Psychiatric Quarterly Open access 31 Aug 2021 48
21 Interferon γ, IL-17, and IL-1β impair sperm motility and viability and induce sperm apoptosis Daniela Andrea Paira, Silene M. Silvera-Ruiz, Andrea Daniela Tissera et al. · Cytokine 22 Feb 2022 47
22 Thyroid hormones and heart failure Felipe A. Martínez · Heart Failure Reviews Book chapter 20 Apr 2016 44
23 The Fixed-dose Combination Drug for Secondary Cardiovascular Prevention project: Improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectives Ginés Sanz, Valentı́n Fuster, Luís Guzmán et al. · American Heart Journal Open access Nov 2011 40
24 Ureaplasma urealyticumandMycoplasma hominisurogenital infections associate with semen inflammation and decreased sperm quality Daniela Andrea Paira, Carolina Olivera, Andrea Daniela Tissera et al. · Journal of Leukocyte Biology 10 Jan 2023 39
25 Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial Alberto J. Lorenzatti, Freddy Goldberg Eliaschewitz, Yundai Chen et al. · Diabetes Obesity and Metabolism Open access Mar 2019 39
26 Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON Alberto J. Lorenzatti, Maria Laura Monsalvo, J. Antonio G. López et al. · Cardiovascular Diabetology Open access 30 Apr 2021 37
27 New evidence on the role of inflammation in CVD risk Alberto J. Lorenzatti, Maria Luz Servato · Current Opinion in Cardiology 27 Apr 2019 37
28 Association between chemosensory stimuli and cesarean delivery in rat fetuses: Neonatal presentation of similar stimuli increases motor activity Juan Carlos Molina, M. Gabriela Chotro · Behavioral and Neural Biology 1991 36
29 Outcomes of Participants With Diabetes in the ISCHEMIA Trials Jonathan D. Newman et al. · Circulation Open access 15 Sep 2021 33
30 Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre‐specified analysis of the Chinese population from the BERSON clinical trial Yundai Chen, Zuyi Yuan, Juming Lu et al. · Diabetes Obesity and Metabolism Open access 9 Mar 2019 32
31 Role of Anti-inflammatory Interventions in Coronary Artery Disease: Understanding the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) Alberto J. Lorenzatti, Maria Luz Servato · European Cardiology Review Open access 2018 29
32 COVID-19 associates with semen inflammation and sperm quality impairment that reverses in the short term after disease recovery María Sol Martinez, Fernando Nicolás Ferreyra, Daniela Andrea Paira et al. · Frontiers in Physiology Open access 11 Jul 2023 26
33 Post Hoc Analyses of SHIFT and PARADIGM-HF Highlight the Importance of Chronic Chagas' Cardiomyopathy Comment on: “Safety Profile and Efficacy of Ivabradine in Heart Failure Due to Chagas Heart Disease: A Post Hoc Analysis of the SHIFT Trial” by Bocchi et al. Félix José Alvarez Ramires, Felipe Martínez, Efraín A. Gómez et al. · ESC Heart Failure Open access 9 Oct 2018 25
34 High ulcerative colitis and Crohn's disease ratio in a population-based registry from Córdoba, Argentina Domingo Cesar Balderramo, Juan José Trakál, Pablo Herrera Najum et al. · Digestive and Liver Disease 30 Jan 2021 23
35 Dopaminergic neurons in the zona incerta modulates ingestive behavior in rats Leonardo H. Tonelli, Emma Chiaraviglio · Physiology & Behavior Oct 1995 23
36 Unmet needs in the management of atherosclerotic cardiovascular disease: Is there a role for emerging anti-inflammatory interventions? Alberto J. Lorenzatti, Brenda M. Retzlaff · International Journal of Cardiology 5 Jul 2016 22
37 Ambulatory Patients with Cardiometabolic Disease and Without Evidence of COVID-19 During the Pandemic. The CorCOVID LATAM Study Ricardo López-Santi, Manlio Fabio Márquez, Daniel Leonardo Piskorz et al. · Global Heart Open access 17 Feb 2021 19
38 Clinical Impact of the Polypill for Cardiovascular Prevention in Latin America: A Consensus Statement of the Inter-American Society of Cardiology Álvaro Sosa-Liprandi, María Inés Sosa Liprandi, Erick Alexánderson et al. · Global Heart Open access 28 Nov 2018 19
39 Rationale and design of a randomized study to assess the efficacy and safety of evolocumab in patients with diabetes and dyslipidemia: The BERSON clinical trial Alberto J. Lorenzatti, Freddy Goldberg Eliaschewitz, Yundai Chen et al. · Clinical Cardiology Open access 2 Jul 2018 19
40 Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials Alberto J. Lorenzatti · European Cardiology Review Open access 23 Apr 2021 17
41 Differential expression of Low density lipoprotein Receptor–related Protein 1 (LRP-1) and matrix metalloproteinase-9 (MMP-9) in prostate gland: From normal to malignant lesions Mónica B. Gilardoni, María Mónica Remedi, Mabel Oviedo et al. · Pathology - Research and Practice Open access 24 Nov 2016 16
42 Cáncer de próstata como hallazgo en resección transuretral Tristán Dellavedova, Rolando Ponzano, Laura Racca et al. · Archivos Españoles de Urología Open access Dec 2010 13
43 Attitudes and Recommendations of Physicians towards Alcohol Consumption and Cardiovascular Health: A Perspective from Argentina Ricardo López-Santi, Sohaib Haseeb, Bryce Alexander et al. · Diseases Open access Sep 2018 12
44 Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE) Carlos I. Ponte-Negretti et al. · Archivos de cardiología de México Open access 29 Jun 2021 11
45 Uric acid crystals in the semen of a patient with symptoms of chronic prostatitis Ruben Dario Motrich, José Javier Olmedo, Rosa Isabel Molina et al. · Fertility and Sterility 22 Feb 2006 11
46 Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussion Raul Dias Santos, Alberto J. Lorenzatti, Pablo Corral et al. · Journal of clinical lipidology Open access Sep 2021 10
47 Amygdaloid input to transiently tyrosine hydroxylase immunoreactive neurons in the bed nucleus of the stria terminalis of the rat Carlos A. Beltramino, Michael S. Forbes, Debra J. Swanson et al. · Brain Research 1996 10
48 HPV and co-infections: impacts on semen inflammation, oxidative stress, and sperm quality Carolina Olivera, Daniela Andrea Paira, Andrés Olmedo et al. · Frontiers in Cellular and Infection Microbiology Open access 26 Mar 2025 9
49 Impact of high-risk and low-risk human papillomavirus infections on the male genital tract: effects on semen inflammation and sperm quality Carolina Olivera, Daniela Andrea Paira, Andrés Olmedo et al. · Frontiers in Cellular and Infection Microbiology Open access 23 Aug 2024 9
50 Current generators and properties of late components evoked in rat olfactory cortex H. Ferreyra-Moyano, Angel R. Cinelli, J.C. Molina et al. · Brain Research Bulletin Apr 1988 9

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.